Nanoviricides, Inc.
NNVCNYSECIK 1379006HealthcareFiscal year ends Jun 30
Reports and events: 210 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0815:28 ET | DEF 14A | Proxy statementPeriod 2026-11-21 | 0001104659-26-114606 |
| 2026-09-2920:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-111952 |
| 2026-09-2820:30 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001104659-26-111390 |
| 2026-07-3010:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-088393 |
| 2026-07-1720:45 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-084668 |
| 2026-05-2110:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-26-064754 |
| 2026-05-2020:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-064544 |
| 2026-05-1500:37 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-061499 |
| 2026-02-1721:30 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001104659-26-016476 |
| 2025-11-2621:30 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-116457 |
| 2025-11-1421:37 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-112644 |
| 2025-11-1421:32 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-112608 |
| 2025-10-0823:02 ET | DEF 14A | Proxy statementPeriod 2025-11-08 | 0001104659-25-097618 |
| 2025-10-0121:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-095676 |
| 2025-09-2920:33 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001104659-25-094527 |
| 2025-05-1520:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001410578-25-001336 |
| 2025-02-1421:30 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001410578-25-000140 |
| 2024-12-1222:00 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-128066 |
| 2024-11-1421:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001410578-24-001991 |
| 2024-10-1520:44 ET | DEF 14A | Proxy statementPeriod 2024-12-07 | 0001104659-24-108620 |
| 2024-09-2720:15 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001410578-24-001650 |
| 2024-08-0920:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-087828 |
| 2024-05-1500:25 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001410578-24-000843 |
| 2024-04-0521:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-044367 |
| 2024-02-1621:53 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-024973 |
| 2024-02-1421:55 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001410578-24-000048 |
| 2024-01-1921:44 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-005254 |
| 2023-12-0421:08 ET | DEF 14A | Proxy statementPeriod 2024-01-13 | 0001104659-23-123215 |
| 2023-11-1421:32 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001410578-23-002484 |
| 2023-11-0723:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-114862 |
| 2023-10-1320:30 ET | 10-K | Annual reportPeriod 2023-06-30 | 0001410578-23-002146 |
| 2023-09-0120:46 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-097802 |
| 2023-05-2520:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-064652 |
| 2023-05-1520:36 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001410578-23-001235 |
| 2023-03-3121:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-040296 |
| 2023-02-1422:01 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001410578-23-000129 |
| 2023-02-1322:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-23-019813 |
| 2022-12-2222:11 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-22-129595 |
| 2022-11-1521:30 ET | DEF 14A | Proxy statementPeriod 2022-12-17 | 0001104659-22-119151 |
| 2022-11-1421:44 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001410578-22-003398 |
| 2022-10-1321:12 ET | 10-K | Annual reportPeriod 2022-06-30 | 0001410578-22-002878 |
| 2022-10-1120:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-107752 |
| 2022-05-1620:35 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001410578-22-001688 |
| 2022-02-1421:31 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001410578-22-000141 |
| 2021-11-2621:30 ET | 8-K | 5.07 Shareholder vote results | 0001104659-21-143985 |
| 2021-11-1521:33 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001104659-21-139231 |
| 2021-10-1220:31 ET | 10-K | Annual reportPeriod 2021-06-30 | 0001104659-21-125343 |
| 2021-10-1210:15 ET | DEF 14A | Proxy statementPeriod 2021-11-20 | 0001104659-21-124918 |
| 2021-09-2115:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-117728 |
| 2021-09-1520:36 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-21-115943 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.